Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
At-Home Answers in Infectious Disease
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Expert Q&A: Adapting to the Expanding Market of At-Home Testing
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Screening Shortfalls and Self-Collected Samples
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Advancements in Antimicrobial Susceptibility Testing: Part 2
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
Comprehensive Coding
Understanding the 2024 CLFS update—and the changes that are still to come.
Billing and Coding: The Value of Clinical Validation
What clinical validation really means—and why every member of the laboratory should understand it.
Can Conducting a Billing Audit Increase My Lab’s Revenue Stream?
Audits can be helpful not just for compliance purposes, but for maximizing reimbursement and maintaining a healthy business.
A Primer for New Lab Sales Managers
Join us and our expert to review important components a sales manager should consider in helping their staff be prepared, professional, and productive.
Expert Q&A: Lab and Pathology Industry 2023 Year in Review
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Year in Review: The 8 Most Important Lab Compliance Stories of 2023
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.